logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

James R Baker, Jr

This inventor holds 58 USPTO granted patents and 34 published patent applications and 9 EPO patents, primarily in Nanoemulsion Vaccines (CPC class A61K). Top assignees: University of Michigan, Nanobio Corporation, Bluewillow Biologics, Inc.. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James R Baker, Jr. Retrieved from https://idiyas.com/inventor/james-r-baker-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 58 

% Patents Active = 70.7

 

Average Co-Inventor Count = 3.8

ph-index = 12

Forward Citations = 908(Granted Patents)

Forward Citations (Not Self Cited) = 695(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal48 out of 3,556 
 
University of Michigan
 patents
silverMedal10 out of 10 
 
Nanobio Corporation
 patents
bronzeMedal2 out of 5 
 
Bluewillow Biologics, Inc.
 patents
4. 2 out of 9 
 
Dendritech Inc.
 patents
5. 1 out of 7,680 
 
The Dow Chemical Company
 patents
where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Nanoemulsion
Vaccines
Adjuvant Compositions
Cancer Therapies
Inflammatory Diseases
Immunogenic Compositions
Pathogenic Microorganisms
Dendrimer Conjugates
Respiratory Syncytial Virus
Herpes Simplex Virus
Autoimmune Disorders
Antimicrobial Compositions
58 patents (USPTO):Explore Patents
1. 12403192 - Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease (2025-09-02),
2. 12076397 - Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration (2024-09-03),
3. 11806318 - Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease (2023-11-07),
4. 11173207 - Adjuvant compositions (2021-11-16),
5. 11147869 - Herpes simplex virus nanoemulsion vaccine (2021-10-19),
6. 11116825 - Cancer vaccine compositions and methods of using the same (2021-09-14),
7. 11083788 - Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease (2021-08-10),
8. 10596251 - Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine (2020-03-24),
9. 10525121 - Nanoemulsion influenza vaccine (2020-01-07),
10. 10206996 - Herpes simplex virus nanoemulsion vaccine (2019-02-19),
11. 10138279 - [object Object] (2018-11-27),
12. 9974844 - Cancer vaccine compositions and methods of using the same (2018-05-22),
13. 9839685 - Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen (2017-12-12),
14. 9801842 - Nanoemulsion therapeutic compositions and methods of using the same (2017-10-31),
15. 9561271 - Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine (2017-02-07),

Title: The Innovative Journey of James R Baker, Jr

Introduction: James R Baker, Jr is a renowned inventor hailing from Ann Arbor, MI (US) known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: James R Baker, Jr holds several patents in various industries, showcasing his diverse range of expertise and creativity in inventing new technologies.

Career Highlights: With a career spanning over two decades, James R Baker, Jr has established himself as a pioneer in the world of inventions, with numerous successful ventures and patents to his name.

Collaborations: Throughout his career, James R Baker, Jr has collaborated with leading companies, research institutions, and universities to bring his innovative ideas to life, further solidifying his reputation as a visionary inventor.

Conclusion: James R Baker, Jr's passion for innovation and relentless pursuit of excellence have cemented his legacy as a trailblazer in the world of inventions, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…